Gene · 3588
Papers2,588
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,588
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Comprehensive Role of High Mobility Group Box 1 (HMGB1) Protein in Different Tumors: A Pan-Cancer Analysis. | J Inflamm Res | 2023 | 36820147 | PubTator, text mining | PubMed |
| A novel DNA damage repair gene-related prognostic model for evaluating the prognosis and tumor microenvironment infiltration of esophageal squamous cell carcinoma. | BMC Med Genomics | 2023 | 36803971 | PubTator, text mining | PubMed |
| MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors. | Clin Cancer Res | 2023 | 36799629 | PubTator, text mining | PubMed |
| Identification and Validation of Immune-Related Genes Diagnostic for Progression of Atherosclerosis and Diabetes. | J Inflamm Res | 2023 | 36798871 | PubTator, text mining | PubMed |
| Interferon alpha inducible protein 6 is a negative regulator of innate immune responses by modulating RIG-I activation. | Front Immunol | 2023 | 36793726 | PubTator, text mining | PubMed |
| Physiological hypoxia improves growth and functional differentiation of human intestinal epithelial organoids. | Front Immunol | 2023 | 36793710 | PubTator, text mining | PubMed |
| Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma. | Front Endocrinol (Lausanne) | 2023 | 36793272 | PubTator, text mining | PubMed |
| Systematic genetic analysis of pediatric patients with autoinflammatory diseases. | Front Genet | 2023 | 36777733 | PubTator, text mining | PubMed |
| Exploring the potential mechanisms of impairment on genitourinary system associated with coronavirus disease 2019 infection: Bioinformatics and molecular simulation analyses. | Asian J Urol | 2023 | 36776826 | PubTator, text mining | PubMed |
| Genetics and Molecular Basis of Congenital Heart Defects in Down Syndrome: Role of Extracellular Matrix Regulation. | Int J Mol Sci | 2023 | 36769235 | PubTator, text mining | PubMed |
| Role of Microglial Cells in the Pathophysiology of MS: Synergistic or Antagonistic? | Int J Mol Sci | 2023 | 36768183 | PubTator, text mining | PubMed |
| Bioinformatics analyses of combined databases identify shared differentially expressed genes in cancer and autoimmune disease. | J Transl Med | 2023 | 36765396 | PubTator, text mining | PubMed |
| Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy. | Front Immunol | 2023 | 36761753 | PubTator, text mining | PubMed |
| EZH2-regulated immune risk score prognostic model predicts outcome of clear cell renal cell carcinoma. | Transl Androl Urol | 2023 | 36760869 | PubTator, text mining | PubMed |
| The TH 22-mediated IL-22 deficiency associated with premature ovarian insufficiency. | Am J Reprod Immunol | 2023 | 36752193 | PubTator, text mining | PubMed |
| Biomarkers in long COVID-19: A systematic review. | Front Med (Lausanne) | 2023 | 36744129 | PubTator, text mining | PubMed |
| Plasma proteins related to inflammatory diet predict future cognitive impairment. | Mol Psychiatry | 2023 | 36737481 | PubTator, text mining | PubMed |
| Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria. | Cell | 2023 | 36736301 | PubTator, text mining | PubMed |
| Multiplex immune profiling reveals the role of serum immune proteomics in predicting response to preoperative chemotherapy of gastric cancer. | Cell Rep Med | 2023 | 36724786 | PubTator, text mining | PubMed |
| Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types. | BMC Cancer | 2023 | 36717836 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3588/papers?page=18